Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 72 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

8%

6 trials in Phase 3/4

Results Transparency

0%

0 of 19 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A
28(57.1%)
Phase 1
10(20.4%)
Early Phase 1
4(8.2%)
Phase 4
4(8.2%)
Phase 3
2(4.1%)
Phase 2
1(2.0%)
49Total
N/A(28)
Phase 1(10)
Early Phase 1(4)
Phase 4(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (72)

Showing 20 of 72 trials
NCT07275788Phase 1Recruiting

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Role: collaborator

NCT07334561Not ApplicableNot Yet Recruiting

Transcranial Electrical Stimulation for Comorbid Depression and Chronic Pain

Role: collaborator

NCT07434518Recruiting

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Role: collaborator

NCT07384390Early Phase 1Not Yet Recruiting

TH-CAR-027 for Grade 4 Gliomas

Role: lead

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT07064109Not ApplicableRecruiting

Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

Role: lead

NCT07043218Phase 1Not Yet Recruiting

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Role: lead

NCT06987916Phase 1Recruiting

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Role: lead

NCT04317885Phase 1Completed

A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects

Role: lead

NCT06951425Early Phase 1Not Yet Recruiting

An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors

Role: lead

NCT06519344Early Phase 1Not Yet Recruiting

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.

Role: lead

NCT06504134Not Yet Recruiting

Gastroesophageal Reflux Disease Diagnostic Trial

Role: collaborator

NCT04517383Not ApplicableRecruiting

Effects of Post-Operative Sedation for Endovascular Thrombectomy

Role: collaborator

NCT04036019Phase 1Completed

A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy

Role: lead

NCT06418685Not Yet Recruiting

Real-World Clinical Study on the Efficacy of Vibrating Capsule (Vibrabot Capsule) for Chronic Functional Constipation

Role: collaborator

NCT06408883Not Yet Recruiting

Effect of Vibration Capsule on Different Subtypes of Functional Constipation

Role: collaborator

NCT06152640Not ApplicableRecruiting

A New Neuroregulatory Technology for the Therapy of AN Based on the Pathological Neural Network of ACC

Role: collaborator

NCT06375161Early Phase 1Recruiting

Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

Role: lead

NCT02707497Phase 2Recruiting

The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia

Role: collaborator

NCT02889666Phase 1Recruiting

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

Role: collaborator